Erythropoietin Hydrogel(Remedor Biomed Ltd)

N/A

Report date: 2023/11/28 20:05:47

Base Information

Drug NameErythropoietin Hydrogel(Remedor Biomed Ltd)

Drug Alias NameN/A

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists

TargetsErythropoietin receptor

Therapy Area/IndicationsDiabetic Foot

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesRemedor Biomed Ltd

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsDiabetic Foot

ATC CodeN/A